David G. Kallend
David G. Kallend publishes mostly in Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research, on topics such as Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins and Cancer, Lipids, and Metabolism.
- World rank
- #289,777 of 7,710,434 ranked researchers
- Rank in United States
- #105,439 of 1,627,098
- Works
- 152
- Citations
- 11k
- Citations per work
- 74.6
What does David G. Kallend research?
David G. Kallend's work is mostly in Medicine (51%), Biochemistry, Genetics and Molecular Biology (16%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences7851.3%
- Medicine7851.3%
- Everything else4328.2%
- Life Sciences3120.5%
- 1Surgery31% of their works
- 2Endocrinology, Diabetes and Metabolism13% of their works
- 3Cancer Research10% of their works
- 4Cardiology and Cardiovascular Medicine8% of their works
- 5Molecular Biology7% of their works
- 6Immunology4% of their works
Research topics
- Lipoproteins and Cardiovascular Health
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Cancer, Lipids, and Metabolism
- Cholesterol and Lipid Metabolism
- Atherosclerosis and Cardiovascular Diseases
- Cardiac Imaging and Diagnostics
- Cerebrovascular and Carotid Artery Diseases
- Pharmaceutical Economics and Policy
Which keywords describe David G. Kallend's research?
The keywords of their largest research topics: Statins, Cardiovascular Disease Prevention, Cholesterol-lowering, Cholesterol, Atherosclerosis, Cardiovascular Disease, Metabolic Syndrome and Fatty Acid Synthase.
- Generic Drugs
- Drug Development Costs
- Coronary Artery Disease
- Inflammation
- Metabolism
- Magnetic Resonance Imaging
- Fatty Acid Synthase
- Cardiovascular Disease
- Cholesterol
- Cardiovascular Disease Prevention
- Statins
- Cholesterol-lowering
- Atherosclerosis
- Metabolic Syndrome
- Lipid Metabolism
- LXR
- Immune Response
- Cardiac Imaging
- Carotid Artery Stenosis
- Endarterectomy
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Statins1292 topics
- Cardiovascular Disease Prevention991 topic
- Cholesterol-lowering991 topic
- Cholesterol833 topics
- Atherosclerosis663 topics
- Cardiovascular Disease371 topic
- Metabolic Syndrome371 topic
- Fatty Acid Synthase301 topic
- Lipid Metabolism301 topic
- Magnetic Resonance Imaging212 topics
- LXR161 topic
- Metabolism161 topic
- Immune Response131 topic
- Inflammation131 topic
- Cardiac Imaging111 topic
- Coronary Artery Disease111 topic
- Carotid Artery Stenosis101 topic
- Drug Development Costs101 topic
- Endarterectomy101 topic
- Generic Drugs101 topic
Where does David G. Kallend work?
David G. Kallend's main affiliation in the publication record is Doctors Company (United States), United States.
How many publications and citations does David G. Kallend have?
OpenAlex counts 152 works and 11,344 citations for David G. Kallend, an h-index of 40, ranking #289,777 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about David G. Kallend. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.